ClinicalTrials.gg
CompletedNCT02395185Updated Dec 15, 2017Results posted

A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants

An interventional study of Milk bottle administration and Water bottle administration in Clubfoot, sponsored by Shriners Hospitals for Children. Completed. Open to participants aged 1 Day to 6 Months. Per ClinicalTrials.gov, last updated 2017-12-15.

Sponsored by Shriners Hospitals for Children · Not applicable, Interventional, and Supportive care

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
1 Day to 6 Months
Sex
All
01

Study summary

While it has been shown that sucrose or milk ingestion decreases pain responses in heel sticks, no study up to this point has determined the best intervention for decreasing the pain response during casting for clubfoot deformity.

The goal of this study is to investigate the effect of three different non-pharmacologic interventions (sucrose, milk, water) on pain response during clubfoot casting.

This study will allow us to discern the best non-pharmacologic intervention for pain control during clubfoot casting and to provide a more pleasant, comfortable experience for patients and families.

Read the detailed description

Clubfoot deformity in newborns is common, occurring in 1-2/1000 births. Treatment of this deformity has shifted from surgical to non-surgical management. The non-surgical management includes utilizing the Ponseti technique of manipulation and casting, followed by Achilles tenotomy and brace application. The newborn undergoes, on average, 4-6 casts before the foot deformity is corrected. During this manipulation and casting, the infants can become fussy and irritable. This irritability is likely due to discomfort felt from the manipulative process and subsequent casting.

Studies that have focused on decreasing the pain response to heel sticks for laboratory testing in the neonatal intensive care units used sucrose or milk ingestion and swaddling in newborns to decrease pain responses. Both sucrose and milk have been shown to decrease the pain response as measured by the Premature Infant Pain Profile (PIPP) or the Bernese Pain Scale for Neonates. In addition, other pain scales have been used in newborn babies including the CRIES, CHIPPS, NIPS, and COMFORT scales to evaluate the effectiveness of pain relieving interventions. These scales were used alongside objective physiologic measurements such as heart rate, heart rate variability (HRV), respiratory rate, and oxygen saturation.

While it has been shown that sucrose or milk ingestion decreases pain responses in heel sticks, no study up to this point has determined the best intervention for decreasing the pain response during casting for clubfoot deformity. The goal of this study is to investigate the effect of three different non-pharmacologic interventions (sucrose, milk, water) on pain response during clubfoot casting, allowing us to discern the best non-pharmacologic intervention for pain control during clubfoot casting and to provide a more pleasant, comfortable experience for patients and families. A secondary objective is to investigate whether or not family environment or the level of anxiety felt by the parents impacts the pain felt by the infant during the casting process.

02

Conditions studied

  • Clubfoot

Browse trials for

03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's enrollment of 33 is below the median of 38 across 40 interventional studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

Shriners Hospitals for Children is the lead sponsor of 56 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 6 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • idiopathic clubfoot deformity
  • undergoing clubfoot casting for correction

Exclusion criteria

Exclusion Criteria:

  • cannot use a bottle for feeding
  • on solid food
  • have had surgery
  • have been given an analgesic within three hours prior to data collection
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Experimental
    Milk

    Milk bottle administration

    Other: Milk bottle administration · Other: Water bottle administration · Other: Sucrose bottle administration

  • Experimental
    Water

    Water bottle administration

    Other: Milk bottle administration · Other: Water bottle administration · Other: Sucrose bottle administration

  • Experimental
    Sucrose

    Sucrose bottle administration

    Other: Milk bottle administration · Other: Water bottle administration · Other: Sucrose bottle administration

Interventions

  • OtherMilk bottle administration

    Patients are given a bottle of milk during the casting process.

  • OtherWater bottle administration

    Patients are given a bottle of water during the casting process.

  • OtherSucrose bottle administration

    Patients are given a bottle of sucrose during the casting process.

06

What researchers measure

Primary outcomes

  1. NIPS (Neonatal Infant Pain Scale)

    Each cast visit will be videotaped before, during, and after casting, and later reviewed for subjective evaluation of pain using NIPS (Neonatal Infant Pain Scale). The NIPS examines six behavioral groupings that contribute to a pain score ranging from 0 to 7: facial expression (relaxed muscles or grimace), cry (no cry, whimper, or vigorous cry), breathing patterns (relaxed, change in breathing), arms (relaxed/restrained, flexed/extended), legs (relaxed/restrained, flexed/extended), state of arousal (sleeping/awake, fussy). Scoring will take place by a trained study personnel blinded to the contents of the bottle. Scoring for all measures will be recorded at minute intervals. A pre casting score from the average of the first 3 minute scores prior to casting; a during casting score from the average of the scores at 1 minute intervals during casting; and a post casting score from the average of the 3 minute scores post casting. Scores are categorized as 0 no pain, to \>4 severe pain.

    Time frame: Scoring will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.

Secondary outcomes

  1. Heart Rate

    Heart rate will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

    Time frame: Heart rate will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.

  2. Oxygen Saturation

    Oxygen saturation will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

    Time frame: Oxygen saturation will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting

07

Results

Posted Dec 15, 2017

Participant flow

53 participants were assessed for eligability. 33 patient participants and their guardians were enrolled in the study from 3/13/13 to 9/17/14 at their initial clinical visit. A total of 131 casts were performed.

Participant flow — Overall Study
MilestoneAll Participants
Started33
Sequence 1 (s,s,m,m,w,w)2
Sequence 2 (w,s,s,m,m,w)2
Sequence 3 (w,w,s,s,m,m)2
Sequence 4 (m,w,w,s,s,m)2
Sequence 5 (m,m,w,w,s,s)2
Sequence 6 (s,m,m,w,w,s)2
Sequence 7 (s,s,w,w,m,m)2
Sequence 8 (m,s,s,w,w,m)2
Sequence 9 (m,m,s,s,w,w)2
Sequence 10 (w,m,m,s,s,w)2
Sequence 11 (w,w,m,m,s,s)2
Sequence 12 (s,w,w,m,m,s)2
Sequence 13 (s,m,w,m,s,w)2
Sequence 14 (w,s,m,w,m,s)2
Sequence 15 (s,w,s,m,w,m)2
Sequence 16 (m,s,w,s,m,w)1
Sequence 17 (w,m,s,w,s,m)1
Sequence 18 (m,w,m,s,w,s)1
Completed33
Not completed0

Outcome measures

PrimaryNIPS (Neonatal Infant Pain Scale)

Each cast visit will be videotaped before, during, and after casting, and later reviewed for subjective evaluation of pain using NIPS (Neonatal Infant Pain Scale). The NIPS examines six behavioral groupings that contribute to a pain score ranging from 0 to 7: facial expression (relaxed muscles or grimace), cry (no cry, whimper, or vigorous cry), breathing patterns (relaxed, change in breathing), arms (relaxed/restrained, flexed/extended), legs (relaxed/restrained, flexed/extended), state of arousal (sleeping/awake, fussy). Scoring will take place by a trained study personnel blinded to the contents of the bottle. Scoring for all measures will be recorded at minute intervals. A pre casting score from the average of the first 3 minute scores prior to casting; a during casting score from the average of the scores at 1 minute intervals during casting; and a post casting score from the average of the 3 minute scores post casting. Scores are categorized as 0 no pain, to \>4 severe pain.

Time frame:
Scoring will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.
Reported as:
Mean · units on a scale
NIPS (Neonatal Infant Pain Scale)
units on a scaleMilkWaterSucrose
NIPS pre casting2.28 ± 2.381.63 ± 2.121.84 ± 2.18
NIPS casting0.91 ± 1.262.22 ± 2.010.63 ± 1.27
NIPS post casting2.11 ± 2.371.49 ± 2.290.69 ± 1.53
SecondaryHeart Rate

Heart rate will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

Time frame:
Heart rate will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting.
Reported as:
Mean · bpm
Heart Rate
bpmMilkWaterSucrose
pre casting152.72 ± 20.45145.69 ± 17.12155.9 ± 15.71
casting152.54 ± 12.87152.59 ± 9.03154.33 ± 24.55
post casting147.2 ± 12.05143.89 ± 13.06149.78 ± 12.99
SecondaryOxygen Saturation

Oxygen saturation will be recorded at minute intervals. A pre casting measure from the average of the first 3 minute measures prior to casting; a during casting measure from the average of the measures at 1 minute intervals during casting; and a post casting measure from the average of the 3 minute measures post casting.

Time frame:
Oxygen saturation will be recorded at minute intervals starting at 2 minutes prior to casting and ending at 3 minutes post casting
Reported as:
Mean · percentage of SpO2
Oxygen Saturation
percentage of SpO2MilkWaterSucrose
pre casting98 ± 1.5797.52 ± 2.2698.33 ± 1.63
casting97.38 ± 1.2697.56 ± 3.2394.32 ± 12.43
post casting98.07 ± 2.0797.85 ± 2.3498.18 ± 1.62

Adverse events

Collected over up to four weeks after study participation. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Sucrose—0/29 (0%)1/29 (3.4%)
Milk or Formula—0/26 (0%)0/26 (0%)
Water—0/26 (0%)0/26 (0%)
Most frequent other events
Most frequent other events
EventSucroseMilk or FormulaWater
Gastrointestinal disorderGastrointestinal disorders1/290/260/26

Baseline characteristics

Analysis included 43 casts receiving sucrose, 37 casts receiving milk or formula, and 42 casts receiving water

Age, Customized
Age, Customized(participants)All Participants
<=18 years33
Between 18 and 65 years0
>=65 years0
Age, Continuous
Age, Continuous(days)All Participants
Mean17.9 ± 20.5
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female9
Male24
Region of Enrollment
Region of Enrollment(participants)All Participants
United States33
08

Study locations

No study locations are listed for this record.

09

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2013, a primary completion of Oct 2014 and a completion of Oct 2014. It does not say whether these dates are actual or estimated.

Results were first posted in Dec 2017, 3 years 2 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 16, 2015
First posted
Mar 20, 2015
Start
Jan 2013
Primary completionActual
Oct 2014
CompletionActual
Oct 2014
Results first posted
Dec 15, 2017
Last update
Dec 15, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 15, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02395185
Lead sponsor
Shriners Hospitals for Children
Collaborators
Kosair Charities, Inc., University of Kentucky
Responsible party
Todd Milbrandt (MD, Shriners Hospitals for Children) — Principal investigator
First posted
Mar 20, 2015
Start date
Jan 2013
Primary completion
Oct 2014
Completion
Oct 2014
Results posted
Dec 15, 2017
Last update
Dec 15, 2017

Study contacts

Todd M Milbrandt, MD
principal investigator · Shriners Hospital for Children, Mayo Clinic

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion